Wilmington Funds Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Wilmington Funds Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$133K	Buy	+20,940	New	+$144K	0.01%	700

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wilmington Funds Management's ARIA Position: Q2 2014 in Review

Wilmington Funds Management opened a new position in Ariad Pharmaceuticals Inc (ARIA) in Q2 2014: 20,940 shares worth $133K. The stake represents 0.01% of the portfolio and ranks #700 among its holdings.

169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.

Wilmington Funds Management held 20,940 shares of Ariad Pharmaceuticals Inc worth $133K as of Q2 2014.
Ariad Pharmaceuticals Inc was a new Wilmington Funds Management position in Q2 2014.
Ariad Pharmaceuticals Inc made up 0.01% of Wilmington Funds Management's portfolio in Q2 2014, its #700 holding.
169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.